$GH · Guardant Health, Inc. SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for Guardant Health, Inc. ($GH) from November 5, 2026 through November 6, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$GH 10-Q — Guardant Health, Inc.
Strong 36% revenue growth and 180% screening surge are offset by a widening loss, testing whether growth can translate to profitability.
$GH 8-K — Guardant Health, Inc.
A 36% revenue beat and raised guidance collided with a widening GAAP loss and higher cash burn, driving a double-digit after-hours selloff.